Baird raised the firm’s price target on Iqvia to $226 from $221 and keeps a Neutral rating on the shares. The firm expects midpoint-plus 4Q23 results and affirmation or better of previously issued 2024 preliminary outlook.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IQV: